Hedgepath Pharmaceuticals Inc., of Tampa, said its corporate name was changed to Inhibitor Therapeutics Inc. and the ticker symbol for its common and preferred stock on the Over-the-Counter Markets was changed to INTI from HPPI, both effective when trading opened on Aug. 20.